Benefits of the Covid-19 vaccine far outweigh the risks of extremely rare potential side effects, pharma giant AstraZeneca said on Tuesday.
The company’s response, in a statement to IANS, comes amidst furore over the company admitting in UK court documents that its vaccine against Covid-19, developed in partnership with Oxford University, can raise the risk of a rare and serious blood
The AstraZeneca vaccine Vaxzevria was administered in India under the brand name Covishield and manufactured by the Serum Institute of India (SII) | Latest News India
Vax benefits outweigh risks of extremely rare potential side effects: AstraZeneca New Delhi: Benefits of the Covid-19 vaccine far outweigh the risks of
Benefits of the Covid-19 vaccine far outweigh the risks of extremely rare potential side effects, pharma giant AstraZeneca said on Tuesday.The company's response, in a statement to IANS, comes amidst furore over the company admitting in UK .
Vax benefits outweigh risks of extremely rare potential side effects: AstraZeneca newkerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newkerala.com Daily Mail and Mail on Sunday newspapers.